Hysteroscopic myomectomy for submucosal type 2 fibroids with cold enucleation technique and complete fibroid extraction using a double-lumen intracervical cannula.

OBJECTIVE: To introduce a new double-lumen intracervical cannula designed to allow a single-step hysteroscopic myomectomy with nonfragmented complete fibroid extraction after cold enucleation of submucosal type 2 fibroids, avoiding complications related to the use of energy and hypo-osmolar solutions. DESIGN: Video article depicting the use of a new double-lumen intracervical cannula for single-step hysteroscopic cold myomectomy, according to our institutional care guidelines and after obtaining the patient's informed consent. (The publication of this video has been authorized by the Institutional Ethics Committee of CES University in Medellín, Colombia.) SETTING(S): Private infertility clinic. PATIENT(S): A 45-year-old woman with abnormal uterine bleeding consisting of polymenorrhea and hypermenorrhea, nonresponsive to medical treatment, caused by three type 2 (FIGO leiomyoma subclassification system) submucosal fibroids of 17, 15, and 13 mm with more than 80% of intramyometrial component. INTERVENTION(S): Hysteroscopic enucleation of three submucosal fibroids performed by blunt dissection using the 30° Bettocchi hysteroscope's bevel under continuous observation of the avascular subcapsular plane of the fibroids. Once full enucleation was attained, cervical dilatation to 12 mm with Hegar plugs was performed followed by intracervical placement of a newly designed double-lumen intracervical cannula that allows the concomitant introduction of the Bettocchi diagnostic hysteroscope and a 5-mm laparoscopic tenaculum into the uterine cavity for complete nonfragmented fibroid extraction under direct visualization. MAIN OUTCOME MEASURE(S): Complete and unfragmented fibroid extraction in a single intervention, absence of surgical complications, and postoperative course. RESULT(S): Ambulatory hysteroscopic myomectomy of three submucosal type 2 fibroids was successfully performed by blunt enucleation and complete nonfragmented fibroid extraction using the double-lumen intracervical cannula. The total operative time was 32 minutes, and the total amount of distension media (normal saline) used was 800 mL with a liquid balance of 50 mL. No surgical or anesthesia-related complications occurred. In the postsurgical evaluation, the patient classified her pain as minimal, giving it a score of 1 on a pain scale of 1 to 5 (in which 1 is the lowest and 5 the highest pain perception). When asked about the level of satisfaction with the surgical procedure, the patient reported the highest degree of satisfaction with a score of 5 on a satisfaction scale of 1 to 5 (in which 1 is the lowest and 5 the highest satisfaction). The patient reported having postsurgical regular menstrual cycles every 28 days and 3 bleeding days without hypermenorrhea. CONCLUSION(S): An efficient hysteroscopic myomectomy of submucosal type 2 fibroids with deep intramyometrial component can be performed with complete and nonfragmented fibroid extraction in a single intervention by using a newly designed double-lumen intracervical cannula. This technique allows the completion of the surgery without the need of a resectoscope, electrosurgery, or hypo-osmolar uterine distension media, thus avoiding potential complications such as thermal-induced myometrial injury and hyponatremia; a second surgical intervention will not be required because the fibroid enucleation is complete. The procedure can be performed with the use of a diagnostic hysteroscope that is widely available in gynecologic practices. (Acknowledgment: The authors thank Dr. David Olive for the invaluable help and guidance with this surgical technique and video article.).

Cirurgia robótica em ginecologia: atualidade e perspectivas / Robotic surgery in gynecology: current and perspectives

No ano de 2018, aproximadamente 549.000 cirurgias robóticas em ginecologia foram realizadas no mundo, ocupando o segundo lugar em volume de procedimentos. Estudos sugerem superioridade ou equivalência dessa tecnologia em relação à cirurgia laparoscópica, porém o custo, a disponibilidade e o treinamento limitam sua adoção. Nesta revisão narrativa, os principais benefícios e limitações dos procedimentos ginecológicos robóticos foram analisados. O uso de robôs na histerectomia para o tratamento de lesões benignas apresentou menor incidência de lesões iatrogênicas e de sangramentos em relação à laparoscopia convencional. Na miomectomia robótica, além de menor taxa de complicações, maior volume de miomas retirados foi observado. A cirurgia robótica tem sido bem-sucedida para cirurgias de estadiamento no câncer de endométrio em estágios precoces (I e II), devido à menor taxa de complicações em relação à cirurgia aberta e aos resultados satisfatórios obtidos em mulheres obesas. A histerectomia robótica realizada no tratamento de câncer de colo do útero apresentou menor perda sanguínea em parte dos estudos, porém um ensaio clínico recente demonstrou maior mortalidade no grupo dos procedimentos minimamente invasivos. Espera-se que, com a redução dos custos e a ampliação dos treinamentos, a cirurgia robótica seja uma ferramenta complementar às modalidades já existentes.(AU)

In 2018, 549,000 robotic gynecology surgeries were done in the world, ranking second in volume of procedures. Studies suggest the superiority or equivalence of this technology over laparoscopic surgery, but its cost, availability, and training limit its adoption. In this narrative review, the benefits and limitations of robotic gynecological procedures were investigated. Using robots in hysterectomy for the management of benign lesions showed a lower incidence of iatrogenic lesions and bleeding compared to conventional laparoscopy. In robotic myomectomy, besides a lower complication rate, a larger volume of removed fibroids was noted. Robotic surgery has been successful in the early stages (I and II) endometrial cancer staging surgeries, because of the lower complication rate compared to open surgery and the satisfactory results achieved in obese women. Robotic hysterectomy performed in the treatment of cervical cancer showed less blood loss in part of the studies, but a recent clinical trial showed higher mortality in the minimally invasive procedures group. It is desired that with the reduction of costs and the spread of training robotic surgery will be a complementary tool to existing modalities.(AU)

TeleCondutas: sangramento uterino anormal / TeleGuides: abnormal uterine bleeding

Sangramento uterino anormal (SUA) é caracterizado por diferentes padrões de sangramento menstrual que variam de alteração no volume, irregularidades na duração e no ciclo menstrual. A condição costuma impactar na qualidade de vida das mulheres, sendo um problema de saúde frequente no atendimento da Atenção Primária à Saúde, acometendo cerca de 10% das mulheres em idade reprodutiva. As principais causas do sangramento uterino anormal são disfunções ovulatórias, gravidez, anormalidades estruturais, distúrbios de coagulação e causas iatrogênicas. Esta guia apresenta informação que orienta a conduta para casos de sangramento uterino anormal no contexto da Atenção Primária à Saúde, incluindo: classificação, etiologias de SUA por faixa etária, avaliação diagnóstica, tratamento, encaminhamento para serviço especializado.